The effect of spike mutations on SARS-CoV-2 neutralization.

Saved in:
Bibliographic Details
Title: The effect of spike mutations on SARS-CoV-2 neutralization.
Authors: Rees-Spear C; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Muir L; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Griffith SA; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Heaney J; Advanced Pathogens Diagnostic Unit, Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London W1T 4EU, UK., Aldon Y; Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., Snitselaar JL; Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., Thomas P; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Graham C; School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK., Seow J; School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK., Lee N; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Rosa A; The Francis Crick Institute, London NW1 1AT, UK., Roustan C; The Francis Crick Institute, London NW1 1AT, UK., Houlihan CF; Advanced Pathogens Diagnostic Unit, Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London W1T 4EU, UK; Research Department of Infection, Division of Infection and Immunity, University College London, London WC1 6BT, UK., Sanders RW; Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., Gupta RK; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Cherepanov P; The Francis Crick Institute, London NW1 1AT, UK., Stauss HJ; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK., Nastouli E; Advanced Pathogens Diagnostic Unit, Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London W1T 4EU, UK; The Francis Crick Institute, London NW1 1AT, UK; Great Ormond Street Institute for Child Health, Infection, Immunity and Inflammation, University College London, London WC1N 1EH, UK., Doores KJ; School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK., van Gils MJ; Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., McCoy LE; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK. Electronic address: l.mccoy@ucl.ac.uk.
Corporate Authors: SAFER Investigators
Source: Cell reports [Cell Rep] 2021 Mar 23; Vol. 34 (12), pp. 108890. Date of Electronic Publication: 2021 Mar 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first